Desq Long
Sign in

Cluster

PHIO-2026-09-22-37d84ddeb413

SEC FORM 4CLUSTER · 2 INSIDERS
$8,640.35

Phio Pharmaceuticals Corp. (PHIO)

Purchase of 8,500 shares across 2 reporting persons.

Transaction Code P · Reporting Persons 2

  • Bitterman Robert J, Chairman, Pres. & CEOPurchase of 2,000 shares at $1.0289 per share.$2,057.80
  • BRADFORD PATRICIA APurchase of 6,500 shares at $1.0127 per share.$6,582.55

Surfaced by rule: 2 distinct insiders, open-market purchases, 7-day window — a deterministic filter, not a recommendation.

Traded Sep 22, 2026 · Disclosed Sep 25, 2026FILED +3 DAYS

Source: SEC Form 4 · 0001683168-26-007321 · filed 2026-09-23 · View filing →

Source: SEC Form 4 · 0001683168-26-007432 · filed 2026-09-25 · View filing →

Permalink →

Composed from the Form 4 as filed with the SEC. Share counts, prices and dates are the filing's own; the disclosure lag is counted in business days from the transaction date to the filing date. What is a Form 4?

Cite this card

Desq Long. "Phio Pharmaceuticals Corp. (PHIO)." Disclosed 2026-09-25. https://desqlong.com/cards/cluster-PHIO-2026-09-22-37d84ddeb413 (retrieved 2026-09-26).